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The immunoglobulin V H gene rearrangement in a primary 
cutaneous, large-cell (centroblastic and inununoblastic) 
B-cell lymphom.a was analyzed using a micromanipula-
tion/single-cell polymerase chain reaction teclmique. In 
all single B cells obtained from CD20-stained skin sections 
that gave a polymerase chain reaction product (eight of27 
in biopsy I) , the same VHDJH rearrangement, consisting of 
DP-54-DIR1-JH3a genes, was detected, with no intraclonal 
nucleotide diversity. Comparison with the most closely 
related germline counterpart showed significantly altered 
complementarity determining gene regions as a result of 
C utaneous B-ceLI lymphomas (CB CL) are rare ly occur-ring neoplasms charac teri zed by the accumulation of clo naHy related B lymphocytes in the skin . Like systemi c (nodular) lymphomas (Lennert eta/, 1975), the different types of cutaneous lymphomas (Willemze ct a/, 1996) 
refl ec t, to some extent, different stages of the B-cell o ntogeny, rangin g 
fi·ont immunoblasti c lymphomas, to centroblastic-centrocytic (follicle 
center) lymphomas, to immunocytomas and plasmocytomas . According 
to the classifica tion recently proposed by the EORTC cutaneous 
lympho ma study group (Willemze et a/, 1996), however, cutaneo us 
lymphomas differ fi:om their systernic counterparts by clinical course 
and therapeutic approaches (WiJ!emze et a/, 1987; Sa ntu cci et a/, 199 :1 ; 
Slater, 1994). 
During their development within the bone marrow, B cells recom-
bine difrerent VH, D , and JH , as we!J as VL-J L gene segments to 
generate multiple templates to r a broad heterogeneity o f antibody 
specificities. This f:1c t can be used fo r th e dia gnosis o fB-cellmalignanc-
ies, because every distinct B-cell clo ne is characterized by an indi vidual 
geno mic sequence resulting fi:om uniqu e V H-0-J l-1> V L -J L reco mbina-
tion events (Lieber, 1992) . Moreover, th e nucleotide seq uences of the 
recombined immunoglobulin heavy and Light chain encoding gene 
segments may provide informati on rega rding th e stage of B-ce ll 
development fro m which a lympho ma descends. Fro m the pattern of 
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somatic mutations, suggesting an antigen-driven selection 
and expansion of this particular B-cell clone. Interestingly, 
in a biopsy obtained fron"l the patient 9 mo later, during 
disease progression (deep muscle infiltration), the 
lymphoma cells again contained the same VHDJH gene 
rearrangement (six of18 in biopsy II) without any further 
son"latic n"lutations. Therefore, it is suggested that the cuta-
neous lymphoma characterized throughout this study des-
cended fron"l postgenninal center B-cells. Key tvOJ•ds: 
cutaneous B-cell lymphoma !Ig gene rea.rmngement. ] Invest 
Dermatol109:541-545, 1997 
somatic muta ti~ns w ithin the V 1-1 / V L genes one may determine w hether 
the clonal B-cell expansion took place before, during, or after antigen 
selection (MacLennan and Gray J 986; B erek et a/, 1991; Ki.ippers et a/, 
1993) resulting in pregerminaJ center, genninal center, or postgerminaJ 
center cell lymphomas, respec ti vely. These studies have systematica lly 
been ca rried o ut for sys temi c non-H odgkin's B-celllymphomas (1-:lum-
mel ct a/, '1994) . For CBC L such data are not yet ava ilabl e but may 
provide an impo rtant input from the molecular biologic poin t of view 
i11to the furth er improvement of the classi·fica tion of such diseases 
(R..ijlaarsdam et a/, 1996). 
T h e technique of single- cell mi cromanipulation followed by poly-
merase chain reaction (PCR ) amplifi ca tio n o f the particular lg-gene 
recombined in this celJ is very usefu l in studying the immun oglobulin 
genes in B-ce!J .lympho mas (Ki.ippers et a/, 1994; Ki.ippers et a/, 1995). 
Lympho ma cells may be "pi cked" under visuaJ control fi·om dWerent 
loca lizatio ns of a histologic skin secti on that has been stained with 
monoclonal antibodies for lineage-specific membrane surface antigens. 
Using this techniqu e we analysed tb e clonal immunoglobulin gene 
VH rearrangement in a patient with a large-cell centrob.lastic to 
inmlUn oblas tic cutaneous B-cell lymph oma at di ffe rent stages during 
progressio n. 
M ATE R IAL AN D METH ODS 
Patient A -19-y-o ld fem ale present<!d w ith bluish- red ind urated pb q ues (first 
;lppearin g in Septembe r 199-1) and pa rt ially u lce ra ted nod u les on the ri ght low<! r 
leg. The fi rst biopsy (sa mpl e I) was take n fi·o m th e right lower leg in I ccember 
1994. the second (sa mpl e 2) d uri ng disease progressio n in Septem b.:r 1995. A 
cl ini ca l staging carried o ut in D<!c<! ln ber 199-1. as wdl as 6 m o later. ai)d 
incl ud ing x-ray, compu ter tom ography, so nogrn phy, blood analysis. and bone 
lll:tn:ow bi op:o:y, d id nor show internal in volve nt ent. T he patien t was treated 
w ith a C H O P regimen (six cycles: cyclo phosp han1idc. adriblas tin c, vincri stin e , 
p redniso ne) resul t ing in partial re m iss io n. As ea rl y as 8 w k b ter th e pa ti ent 
presented d isease progressio n and disseminati o n (lymph node :1nd ga5trognen ticus 
muscle in volverne m) com pli cated by deep veno us th rom bosis, dyspnoea. and 
ea rl y rena l f.1 ilure. In cto be r 1995 the "'ho le righ t leg "·as treated by electron 
bea m irradia tion. C hem otherapy (B-A LL regimen , incl ud ing m cthotre,;are . 
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Figure 1. Micromanipulation to obtain single CD20-stained B ccUs 
fr01n a tissue section of a cutaneous B-cell lymphoma . For detai ls see 
Mnrerinl '"'" Merhods. (A) The HJ-pm thick cryosec ti o n: (B) pickin g :1 single 
C D20-posiri ve cell by hyd rauli c micromanipulation; (q th e tissue secti o n after 
micromanipulati on. Srnlc /Jars , 25 ~lm . 
chlo rambu ci l, doxorub icin , dexamethasone) induced a redu ctio n of intra-
abdominal tumor mass but could no t stop disease progression. In June 1996 
th e paticm di ed. 
Histology, immunhistochcmistry, a nd molecular biology The histo iOb'Y 
showed th e diffuse infil tration of the de rmis and subcutis mainl y with large 
irnmunoblast- and ccntrobbst-like cdls that were immuno histochemical ly 
characteri zed as CD20+ , CD30- , vcl-2+. Most of th e cells expressed th e 
lan1bda light chain isotype. Nearly I 00% of th e path ologic cell popu lation was 
in pro li ferat ion. In th e biopsy obtained in September 1995 (sample 2), deep 
infil tration by C D20-pos itive tumor 13 cells and destructio n of the muscul:1r 
structure became obvious. R..outine mo lcc ul :-~ r biologic ana lysis showed a 
dominant monoclonal IgH gene rea rran ge ment :1111pli fied by VH fi·amework 
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Table I. Oligonucleotide primers for single-cell PCR analysis 








JH I ,2,4,5 extern (3') 
Jl-1 3~(3 ' ) 
JH6 extern (3 ' ) 
JH I ,4 in tern (5' ) 
JH2 intern (5 ') 
JH3 intern (5') 
J 1-16 intern (5 ' ) 
Nucleotide seguenct! 
5' CC T C A CTC AAC CTC(T) T CC TC C AAC C 3 ' 
5' C T CCT CCC C T G GTG AAA CCC ACA CA 3 ' 
5' CCC , T C C TC ACA CTC TCC TCT CCA G 3' 
5' G ACC CTG TCC C T C ACC TC C G(A)CT GTC 3' 
5' AAA AAC C GC , GAG T T CTG AG (A)G A 3' 
5' ACC TGT GCC ATC T CC CCC CAC ACT G 3' 
5' ACC C TG GTC ACC GTC TCC T CA GGT 3 ' 
5' AC A ATC GTC ACC CTC T C T T CC GGT A 3 ' 
5' ACC ACG GTC ACC CTC T C T C A CCT 3' 
5' CAC GGT G AC CAC 'CT (T )CCC CCC 3' 
5' CAC ACT CAC CAC GCT CCC ACC CCC 3' 
5' GAC GCT GAC CAT TGT CC TTG G C 3' 
5' GAC GGT G AC CGT CGT CCC TTT(G) GCC 3' 
·'Prilll !;;" I"S were desigucd according to KOppers t l t~l. 19Y4) 
3/JH primers fi·om toto! DNA obmin ed From par:1ffin-embedded skin sec ti ons 
(Wi ll cmze er a/, 1996) . Th e lyn1 phom:J therefore was classili ed as a large 13 -ce ll 
lymphoma (irnmunobbstic/ centroblasti c) o f the leg (Vermeer <'I 111, I 996). 
Obtniuiug .< it~Ric a·lls from srniucd skill serrions by tnicrolllftllipnlllfion Frozen skin 
sectio ns ( I 0-pm thi ck) were stained with th e C D20 :1ntibody (Dako, Hambu rg. 
Ge rm:1n y) using bio tin ybted Fob ;mti- mousc and strep t:1 vidine- :dbline phos-
ph:ltose complexes (Dako) as develop ing reogents. Control sections were st:Jin ed 
with C D3 :l ntibodies. After w:1shing, bound albline phosphotose was visuali zed 
by st~ining with Nl'w Fuchsin . The sli des were counterstaincd w ith l1 cmatox-ylin . 
Single ce lls were mobili zed under the microscope (Nikon, Dusseldorf, 
Ge nnon y) with the help of a hydrauli c micromanipul:1to r (Narishige, DUsseldorf, 
Ge rmon y) using GOO X magni fic;n io n. Th en, single cells were aspirated into a 
micropipette (Norishige) , put into 20 p.l PC R buffer suppl emented by 1 ng 
rRNA per Jll (bo th fi·om 13oehringe r, Mannheim . German y), and sto tt!d :lt 
- 20°C. Photographs were taken before :1nd :~fte r the tni cromonipubtion of 
e:1ch cell (Pig lA-C) . 
Mol1'wlar biolosir mwlysis '!(the ~~ /-/ gl'lli'S A set of ol igo nucleotide primers w:1s 
used for PC R. amp lifi catio n of rea rr:1nged V1_1 ge nes (Table I ). Six V1_1 gene 
f.1mi ly specifi c primers were used together with J 1.1 specifi c o li go nuclco ticl t!s 
(Kiippers r l nl , 1993). A semi - nested PCR. :1pproach was chosen. In the flrSt 
round of amplifi ca ti o n, six V1_1 gene primers together with the outer (3') J1.1 
primer mix were used sinudtaneously in one tube. For th e second round of 
:1 mpl ific:Jtion, aliguors of th e tirst round we re reampli f1ed using th e same V1-1 
primers but nested JJ-I primer mi xes in separ~te reac tio ns for e ::tc h VI-I gene 
f:1mi ly. 13efo re P I<., tht! single cells were incub:1ted with 0.25 mg proteinase 
I< per ml (Boehringe r) for 55 min :lt 50° and :1dditionally at 95°C for 10 1nin 
(e nzyme inactiv:Jtio n). The reaction mi x (50 pi) for th e first ro und of 
amplifi cation contained PC I ~ buffer (Boehringer), 2 .5 p.M MgC I2 (13oehringer) , 
200 pM o f each nucleotide (dATI', ci CTG , dGT P. ciTTP; AG S, Heidelberg, 
Ge rm:1n y), 7 nM o f each primer, and 3.5 U Expand High Fidelity T:lg-
polymer:Jse (Boehringe r). PC R. ampli fic:1tio n was ca rried o ut o n a Personal 
Cycler (13iometr:l , Cottinge n, Ge rm any): one cycle at 95°C for 2 min , 65°C 
for ·1 min (when T:lq-polymer:Jse was added). and T!.°C for I min , fo llowed 
by 35 cycles at 95°C for 30 s, 59°C fo r 30 s, 72°C for ·1 min , and fina l 
extension :lt 72°C fo r 5 min . Th e second ro und of P R. was ca rri ed out in 
separate reac tions for each of th e six V1.1 fam il y specitl c primers using I pi o f 
th e amplification product from the first ro und. R.e:1cti on mixture: PC R buffer 
(Perkin-Ehn er, Oberlin gen, German y), I .5 pM MgCI2 (Perkin-Elmer) , 200 ~lM 
of each nucleo tide , 7 nM of each primer, and 5U Tag-polymer:lse (Perkin-
Ehner). The second rou nd cycle program w:1s corried o ut on a TRIO-
Thennoblock (BIOMETR.A) and consisted of one cycle at 95°C fo r 2 min, 
68°C for 5 min (add ition of Tag- po lymerase), and 72° for I tnin, 45 cycles 
at 95°C for 1 min , 6 "1°C (V 1.11, V1.12, V1_15, V1.16 specifi c primers) o r (>5°C (VI-13, v H4) fo r 30 s, and a fina l ex tension at 72°C tor 5 min. A 5-p l aliquo t 
of th e reaction m ixture W:lS analysed on a 2% aga rose gel. 
Strong attention was paid to avo id contamination with DNA. The mic ro-
manipulation, f111;t and second round of PC R were carri ed out sepa rately in 
different rooms. As negative controls . two T ce lls fi·o m CD 3-stained :1djacent 
sec tions were picked during the sa me ex periment. 
The PC R produ cts we re putili ed using a Q IAguick PC !<. purifica tion kit 
(Qiagen, Hilden, Germany) fo llowed by d irect sequencing with the Dye 
Tenninator Cycle Sequencing I<.e:1dy Reaction Kit (Perkin -Elmer) o n a 
Sequencing System 373 (Applied 13iosystems, Weiterstadt, Germany) using 
between 0.5 ond I U ~ll purified PC ! ~ product and 1.5 pi 2 .5 11M of th e f:unil y 
specifi c V1.1 primer. O nce the used J1.1 gene became clear the PC I<. product was 
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Table II. Summary of the single-cell analysis of micromanipulated cutaneous lymphoma B cells 
Experiment 























p 1<. products 
Tor~ I Se<juenced f'tC:liTJ il gt: ll1CiltS 
3 3 3 ILVH3 
-1 -l -l iLVH3 
2 l ILVH3 
5 2 2 ILVH3a 
4 4 4 ILVH3a 
18 1-l 14 VH3 = ILVH3a 
OP-~'i 
!LVII3 
! LV!l )a 
30 
SGf'TFSS YWMS 
TCT GGA TTC ACC TTT AGT A::;::: -- - --- TAT TGG ATG AGC 
40 
WVRQAP GKGLE><l V/\ 
GG GTC CGC CAG GCT CCA GGG AAG GGG C't'G :;AG TGG GTG GCC 
- Y - - AT --- G-'1' --- --- - 1.- -- - -- - - T - --- --- --- -- - -- --- -- - A-- --- -C- --- --A --- --A -- - --- T--
- Y- - AT --- G- T - -- --- - A- --- - -- - T - - - - --- -- - -- --- --- --- A-- -- - C- -- - --A --- --A -- - --- T --
0 A t-l E' T A 5 Figure 2. Nucleotide sequence of the 
VHDJH rearrangement amplified b y PCR 
from single B cells fr01n tissue sections of 
a patient with cutaneous B-celllymphoma. 
ILVl-13 ... representative example of V1_1 genes 
obtained from biopsy sample ·1 (December 
1994), ILVI-13a.. . representariv.: s.:quence 
obtained fi·om biopsy sample 2 (September 
1995) . Nucleotide differences in comparison to 
the most closely related gen11line gene (DP-54, 
Tomlinson er <11, ·1992) are indica ted by bo.l d 
letters; dots show nucleo tide si mi larity. 
CDR2 FRJ 
52 a b c 60 10 
OP- 5 4 
! LV!\3 
ILVH3a 
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CCC 1\GG 1\ 
COR3 
" 
TTG GG GGC CTA GGC CC1' CC 
TTG GG GGC CTl\ GGC CCT CC 
L !\G LGPP 
JH 
DAfOV W 
T GAT GCT TTT GAT GTC 7GG JH3a 
- -GG C-- --- T- - --- ---
- -GC C-- --- T-- -- - - - -
G r r 
scqu (.; !l C<.:d into th e 5' d irectio n w ith the correspo ndin g J H prin1 c.: r. T h e.: 
evaluation was carried our with the help of the so ftware p~ckct "Sequ ence 
Navigato r" (Applied Biosys tems). T he sequ ences were Oillin e analysed using 
the Soft ware " I NA BL T " (crea ted by H.-lei. Althaus) and cOinpared with 
the gene bank "V l3ASE Sequence Di rectory" (Tomlinson cr a/, MR.C Centre 
fo r Prote in Engineering, Cambridge, UK, l lJ96) fo r determining the most 
similar gennline VH genes . 
R._ESULTS 
Microm.anipulation and single-cell PCR data A tota l of 45 single 
C D 20-positi ve B cells were mi cro m anipuhted from fi·ozen tissue 
sec tions (Fig 1) m ade from two skin b iopsies o btain ed in D ecember 
1994 and Septe mber 1995, respectively. Five independen t fu·st ro und 
PC R. experim en ts were ca rri ed o ut o n diffe rent days (Table II) . As 
nega ti ve contro ls, two singleT ceJJ s per experiment were mi cro rnanipu-
lated fi·o m a C D 3-stain ed adjacent section of th e sa m e biopsy o n th e 
same day. Fro m all T ce lls ana lysed , no lg gen e rea rrangem ents w e re 
o bta in ed by PC R. Fro m a to tal of 45 C D20-positive B -ce!Js, "14 (3 1 %) 
yielded amplification products, w hi ch afte r direct sequ en cing were 
fo und to represent identi cal V1-PJ H Gene R ea n:a ngem ents (see below) . 
Analysis of VHDJH gene rearrangetnents in lytnphoma B 
cells Two representati ve V HDJ H-gen e seq ue nces amplified from 
bio psy in D ecember :1 994 (ILVI-13) and September 1995 (ILVI-l3a) are 
shown in Fig 2. All 14 P C R. products seque nced thro ughout thi s 
study were identica.l , independent of th e disease stage at w hich biopsies 
were taken . The V1-1-gene sequence ca rri ed 39 nucleotide differences 
(18.4%) compared with the m ost ho m o logous germline gene (D P-54/ 
VH3-07). It may be assum ed that m ost of th ese nucleotid e substituti o ns 
result fi·om som atic mutatio n because th e vast majm; ty of V H genes 
are known. T he somati c mu tations w ere found to be di stributed 
over the complete VH gene inclu di ng both framework (FR.) and 
complem entarity dete rmining regions (CDR) w ith a significa ntly 
high er number of replacem e nt mutatio ns w ithin the CDRs (Table ill) . 
Furth er ana lysis showed the DP-54 V H gen e to be linked w ith a 
segm ent of seven nucleotides m ost likely descended fi·o m a D ll<.. l , 2 , 
or 5 gene and a JH3a gene segm ent . O bvio usly, at the V1-1D and th e 
Table III. Mutations in the Vh gene obtained front single B 
cells of a patient with cutaneous B-cell ly mphoma 
Mut:ttio ns 
Gene scgn1 ent R.eplaccment Silent 
(FR I)" 3 2 
C DR I 2 0 
Fl<.2 3 4 
CDR 2 8 0 
FR 3 9 8 
Total nu111ber of lllLitations 
C D!<. 10 0 
Fl<. 15 1-l 
'









Dj 1_1 junctio ns, N-sequ ences were introduced during recombinati o n , 
resul ting in a C DR3 of 42 nu cleotides length (Fig 2) . 
D ISCUSS ION 
In recent years it h as b ecom e well established that B-cell ly mph o m as 
m ay appear in the skin , presenting localized nodules and plaque. 
composed of a dense no n ep idermo rro pic follicular and / o r di fl:i.tse 
infiltrate aro und vessels and adnexa, w ith o ut eviden ce of extracutaneous 
manifestation at the time of presentation (Burg er a/, 1984; Sterry and 
H auschild , 1989; Santu cci eta/, 1991; Naga tan i er a/, 1993) . Th e large 
m ajority of th ese primary cutaneous lym pho m as has been shown to 
be descended fi·om cell s no m1ally fo und in fo Lli cle centers of ly mph 
no des (small and large cleaved cells o r centrocytes; la rge non cleaved 
cells o r cen.troblasts) and have th erefore been ca lled pt;mary fo llicle 
center cell lymphoma (PCFCCL), representing a distin ct disease en tity 
with an exce ll ent progn osis (Will emze er a/, 1987). Both radioth erapy 
and C H OP po lych em oth erapy are highly effective m odes of trea tment 
fo r P C FCCL (Rij laarsdam cr a/, 1996) . Primaty cutaneous B-cell 
lympho m as ca n b e distin guish ed fi:o rn pseudolym ph o m a b y immun o -
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histochenti ca l and molecubr biologic ana lysis of the rea rranged 
immunoglob ulin ge nes (La nda c/ nl, 1993; Peris r/ a/, 1995). 
T he diversity of the pri mary antibody repertoire results f.i·om the 
multiplicity of the V, D, J gene segments fo r heavy and light chains 
(co mbinato rial diversily) as well as fi:om th e imprec ision of th e j o inin g 
process Uunctional diversity). T he genera tion o f such a prim:uy 
repertoire does no t requ ire exposure to antigen. A p rocess of somati c 
hypermutation is indu ced by the antigenic chaLl enge . T he selection of 
hi gher affi nity antibod ies by the anti gen resul ts in th e maturati on of 
the immun e response (Berek et a/, 199'1; Betz c/ a/, 1993). 
Gene rea rrangement and mutationa l analysis may not on ly help in 
rhe diagnosis of cutaneous lymphomas but also contribu te to an 
improved class ifica tion of these distinct entiti es. Based on the weLl -
establ ished fuct that naive pregerminal center B cells carry nonmutated 
V genes, w hereas germ inal center B cells and gem1inal center derived 
memo1y B ce Ll s express mutated V region genes (Berek cl a/, 199 1; 
Jacob et nl, 199 1; Klippers cl a/, 1993) , B-cell mali gnan cies were 
classified into those descended fi·om pregerrninal B cells (B-CLL, 
mantle ce ll lymp homa; Meeker et a/, 1988; Humm el e/ a/, 1994) and 
others descended fi·om germinal or postgerrnina l center B cells (fo lli cular 
lymphomas, multiple myeloma, endemic Burkitt's lymph oma ; Ba kkus 
eta/, 1992; Hummel eta/, 1994; C hapman el a/, 1995). Nodular fo lli cle 
center ce ll lymphomas were shown to express highly mutated VI-I 
genes with a high ratio of replacem ent to sil ent mutations in the CDRs 
in comparison with the FRs (Both et al, 1990; Hummel et a/, 1994), 
wi th num ero us intl·aclonal heterogeneities, suggesting that they were 
descended f.i·om germinal center cells in a process of ongoing somatic 
hypermutation (Cleary c/ a/, ] 987) . Furtherm ore, fi·om the mutational 
pattern w ithin th e V ~1 /V L gene, a potential role for antigen-triggered 
growth stimula tion and clonal expa nsion m ay be proposed to play an 
important ro le in th e genesis of lymphoma (Cieaty et a/, 1987; Garbe 
eta/, 1991 ; Ba hler eta/, 1992; Bessudo et al, 1996; Du et a/, 1996). 
T he main problem of the molecular biologic analys is of lymphomas 
is to assure that an amplifica ti on product obtain ed fi·om a ce ll popu lation 
(skin section) by PC H.. represents the lympho ma clone rath er than 
other infiltrati ng non malignantB cells. To study the V gene repertoires, 
libraries have been constru cted by PCR amplifi cation from B-celJ 
pop ulations (see for exa mple, Bessudo rl a/, 1996; Du el a/, 1996), but 
it is difficult to exclude the possibility that sequences have been 
amplified wi th different effi ciencies, resul ti ng in uneq ual representation 
of genes in the libraries. Both of th ese problems may be overcome 
when analysis is perforn1ed o n single cells, fo llowed by di rect sequ encing 
of the PCR prod uct obtained fi·om individual gene rean-angements 
(KOppers el a/, 1995). 
T his approach was used to analyse single B cells obtai ned fi·om ti ssue 
sections of a patient with a prima ry cutan eous B-cell lymph o ma. A 
tota l of 45 CD20-sta in ed cell s was analysed by PCR , ampli fying th e 
rea rranged VHDJH gt!ne segment. P R products could be obtain ed in 
18 cases, fi· m w hi ch 14 were sequ enced. Each nucleo tide sequence 
revealed a DP-54 (VH3)-DJR 1-JH3a gene rea rrangement contain in g 
numerous N-sequences at the DJH and V1-1D junctio ns. T here were 
no other V1_1DJH rearrangements detected, neith er in th e mi cromani pul -
ated B ce lls nor in a total of I 0 CD3-positi ve ceLls obtai ned fi·om an 
adjacent section of the sa me biopsy on the same day (two per PCR. 
experiment). O nly o ne parti cular V1-1DJH rearrangemen t was detected 
in B cells of two independent biopsies. Th is fact makes it more than 
like ly that th e clona ll y expanded mali gnant lymph oma 13-cells we re 
identified. 
Surprisingly, there were no other immunoglobuli n gene rearran ge-
lnents detected, w hich would suggest reactive B ce ll s in th e dermaJ 
in fi ltrate . It may only be specu lated that the absence of reactive B 
cells in both biopsies represems a fea ture of this particubr type of 
lymph oblastic to cenrroblastic B-ce ll lymph oma of the lower leg. In a 
recent study, when ana lys ing the B ce lls infiltrating plaq ue lesions in 
patients w ith mycosis fun goides, we were able to detect difft:rent 
V1-1DJH lg rearrangements suggesting the polyclonal o rig in of the ce ll s 
(Fors te cr a/, 1997, submitted) . 
Comparison of the V 1-1 gene rea rranged in lymphoma cells with th e 
most closely related germli ne gene showed num ero us mutations 
distributed over the who le gene segment. The signifi cantly enhanced 
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ratio of replacement to silent mu tati ons (R: S) within the CD 1<... sugges ts 
an antigen-d ri ven maturati on process o f this particular H-ee l! clo ne, 
found to be typ ical fo r FCCL (Hummel et a/, 1994; Bessudo ct n/, 
J99o; Du ct a/, '1996). C hang and Casali ('1995) , however, observed 
that th e codons for th e CD.K of many gennl ine V1-1 genes are more 
prone to replacement mutatio ns than those used in most other proteins. 
Finding higher R:S ratios for the CO L<... than for the FR segments co uld 
therefore resul t fi·o m random nonselected nucl eo tide base substitutions. 
Eve n taki ng these assumptio ns in to acco unt, the ILVl-13 gene rea rranged 
by cutaneous lymph oma B cells in th is case still shows deduced R:S 
ratios in the CD R 1 /CD R2 that exceed th e expected o nes fi·o m 
random base substitions. O nly some of th e mutations ap pearing w ithin 
the V1-1 gene during a certain immun e response are responsible for the 
maturation of antibody affi ni ty; others - in cl uding silent mutatio ns -
represent a neutraJ background resulting fro m the nature of the intrinsic 
mutational process (MacLennan and G ray 1986; Betz ct a/, 1993). 
Comparing the da ta fi:om our studi es with those of other groups 
(C lea ry el a/, 1987; Humm el eta/, 1994; Bessudo eta/ , 1996), however, 
we co nclude that the lymph oma dt:scended from antigen-stimulated/ 
selec ted B ce lls that have undergone the germJine reac ti on. 
Analysing a tota l of 14 sequences, eight of them fi:om biopsy in 
D ecember 1994 and six from Septe mber 1995, we found no intraclonal 
diversity. T he absence of diversity wi thin th e sequences obtain ed 
supports th e low freq uency of errors made by the Tag polymerase. 
Furthermore, the direct sequencing of PCR products is advantageous 
as rega rds the Tag polymerase errors, as only mistakes introdu ced 
during th e first rounds of th e initial PCR appear in the sequence 
(Klippers et a/, 1995). 
ln the case of mu cosa-associated lymph oid ti ssue (M ALT) 
lymphomas, Du et a/ (1996) showed th at ongoing mutation indicated 
by intradonal variation of the V1-1 gene clearly existed in low-grade 
tumors but was not evident in high-grade tumor ceU popu lati ons. T he 
auth ors suggest that at leas t th e high-grade MALT lymph omas are 
derived ti·om postgerminal memory B cells and that direct antigenic 
stimulati on may play an important role in th e clonal expansion of 
MALT lymph omas. It is possible that in at least some cases of high-
grade lymphomas, the tum or ceLl s partiaLl y lost or no longer preserved 
th e normal ability to respond to the acti va ti on of the hypermutatio n 
mechanism due to acquired add iti onal genetic abnormalities such as 
p53 inactiva ti on (D u c/ a/, 1995) or C-III)'C acti vation (va n Krieken et a/, 
1990). T his is in accorda nce w ith the observa ti on that hi gh-grade 
MALT lymph o mas, unlike low-grade tumors, lose th e growth respo nse 
to 1-Ie/iwbacter pylori T-cell mediated immunologic regula tion (Husse ll 
ct a/, 1993) . 
Taking these assumpti ons into acco unt , we suggest that this primary 
cutaneo us B-ce ll lymph o ma , classifi ed as a large-cell immunoblasti c 
lymphoma of the lower leg, descended fi·o rn antigen-selec ted post 
germinal center memo1y B cells. Further stud ies w iiJ show whether 
tlli s is a genera l phenomenon to r cuta neous B-cell lymph omas of the 
leg, whi ch have been recently characterized as a distin ct enti ty w ith 
an in te rmediate prognosis (Vermeer el a/, 1996) . 
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